申请人:BEIGENE LTD
公开号:WO2021208963A1
公开(公告)日:2021-10-21
Disclosed herein is a compound of Formula (I) for inhibiting both Bcl-2 wild type and mutated Bcl-2, in particular, Bcl-2 G101V and D103Y, and a method of using the compound disclosed herein for treating dysregulated apoptotic diseases.
本文披露了一种用于抑制Bcl-2野生型和突变型Bcl-2(特别是Bcl-2 G101V和D103Y)的化合物(I)以及使用本文披露的该化合物治疗失调的凋亡性疾病的方法。